SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-000906
Filing Date
2023-01-09
Accepted
2023-01-09 08:15:18
Documents
16
Period of Report
2023-01-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 58554
2 ex10-1.htm EX-10.1 185755
3 ex10-4.htm EX-10.4 44558
4 ex99-1.htm EX-99.1 14036
5 ex99-1_001.jpg GRAPHIC 2967
  Complete submission text file 0001493152-23-000906.txt   536799

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xtnt-20230109.xsd EX-101.SCH 3239
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xtnt-20230109_lab.xml EX-101.LAB 34916
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xtnt-20230109_pre.xml EX-101.PRE 22797
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3664
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 23516717
SIC: 2836 Biological Products, (No Diagnostic Substances)